Industrial preparation method for lamivudine

A technology of lamivudine and its compound, which is applied in the field of industrial preparation of anti-hepatitis B virus drug lamivudine, can solve the problems of waste gas, cumbersome operation process, and high corrosion of equipment, and achieve easy implementation, simple preparation, and corrosion resistance big effect

Active Publication Date: 2011-11-09
吉斯凯(苏州)制药有限公司
View PDF10 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The method prepares 5-chloro-1, and the chlorination reaction process of 3-oxathiolane-2-carboxylic acid-(-)-bornyl ester has used the thionyl chloride which is very corrosive to equipment; the reaction process Sulfur dioxide waste gas is produced, which seriously pollutes the environment; the reaction yield of chlorides and N-acetylcytosine is not high, only 66%, and the above factors are not conducive to industrial production
[0007] CN101597281A discloses a kind of preparation method of lamivudine and its intermediate, the method is in the preparation of (2R, 5R)-5-acetyl-[1,3]oxathiolane-2-carboxylic acid (2S -Use acetic anhydride, acetyl chloride in the process of -isopropyl-5R-methyl-1R-cyclohexyl) ester, although yield reaches 90% or 88.5%, the product purity that obtains is low; In preparation (2R, 5R )-5-propionyl-[1,3]oxathiolane-2-carboxylic acid (2S-isopropyl-5R-methyl-1R-cyclohexyl) ester using propionic anhydride, the yield 86%, in the preparation of (2R,5S)-5-(4-amino-2-oxopyridin-1-yl)-[1,3]oxathiolane-2-carboxylic acid (2S-isopropyl In the process of base-5R-methyl-1R-cyclohexyl) ester, silane reagent is used to react with cytosine to form silane double-protected cytosine, and the double-protected cytosine of disilane participates in condensation reaction, although the yield is improved, but The purity of the obtained product is relatively low, and the purity of the lamivudine prepared in this way is also low. It must be recrystallized and purified many times to meet the medicinal requirements. The operation process is cumbersome and it is difficult to realize industrial production.
[0008] The preparation method of lamivudine disclosed above still has some deficiencies. It is necessary to find a method that is simple to operate, safe and environmentally friendly, has high yield and purity, and is suitable for industrial production.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Industrial preparation method for lamivudine
  • Industrial preparation method for lamivudine
  • Industrial preparation method for lamivudine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] (5R)-Acetoxy-1,3-oxathiolane-(2R)-carboxylic acid-[(1′R, 2′S, 5′R)-5′-methyl-2′- Preparation of (1-methylethyl)cyclohexyl] ester (IIIA)

[0067] Compound (II) 5-hydroxyl-1,3-oxathiolane-2-carboxylic acid [(1'R, 2'S, 5'R)-5'-methyl-2'-(1 -Methylethyl)cyclohexyl]ester (200g) was put into a 2L three-necked flask, DMAP (10.16g) and tetrahydrofuran 600ml were added, stirred and dissolved, cooled to -25~-20°C, and diethyl ether was added dropwise within 2~3 hours. Acid anhydride 99ml, continue to react for 45-60min after the dropwise addition, then slowly add 10% sodium carbonate aqueous solution dropwise to adjust the pH to 7, transfer it to a separatory funnel, let stand to separate layers, extract the water layer twice with 100ml tetrahydrofuran, collect organic layer, dried over anhydrous magnesium sulfate overnight, filtered, the filter cake was washed with a small amount of tetrahydrofuran, the filtrate was concentrated under reduced pressure at 60°C, recrystallized wi...

Embodiment 2

[0069] (5R)-propionyloxy-1,3-oxathiolane-(2R)-carboxylic acid-[(1′R, 2′S, 5′R)-5′-methyl-2′ Preparation of -(1-methylethyl)cyclohexyl]ester (IIIB)

[0070] Compound (II) 5-hydroxyl-1,3-oxathiolane-2-carboxylic acid [(1'R, 2'S, 5'R)-5'-methyl-2'-(1 -Methylethyl)cyclohexyl]ester (200g) was put into a 2L three-necked flask, DMAP (10.16g) and tetrahydrofuran 600ml were added, stirred and dissolved, cooled to -25~-20°C, and propane was added dropwise within 2~3 hours. Acid anhydride 134ml, continue to react for 45-60min after the dropwise addition, then slowly add 10% sodium carbonate aqueous solution dropwise to adjust the pH to 7, transfer it to a separatory funnel, let stand to separate layers, extract the water layer twice with 110ml tetrahydrofuran, collect organic layer, dried over anhydrous magnesium sulfate overnight, filtered, the filter cake was washed with a small amount of tetrahydrofuran, the filtrate was concentrated under reduced pressure at 60°C, recrystallized wit...

Embodiment 3

[0075] 5S-[5-(4-acetylamino-2-oxo-1(2H)-pyrimidine base)]-1,3-oxathiolane-2R-carboxylic acid-[(1′R,2 Preparation of 'S, 5'R)-5'-methyl-2'-(1-methylethyl)cyclohexyl]ester (VA)

[0076] Put 25.5g of N-acetylcytosine, 0.77g of ammonium sulfate, 22.0ml of hexamethyldisilazane and 500ml of chloroform into a 1L three-necked flask, stir and raise the temperature and reflux for 2 hours until the reaction solution is dissolved and clear, and cool to the internal temperature 0°C to obtain a chloroform solution of compound (IVA); under nitrogen protection, add 44.0ml of iodotrimethylsilane dropwise to the chloroform solution of compound (IVA) while stirring while maintaining the internal temperature at 0°C, dropwise within 1.5 to 2 hours After the addition, 100ml of compound (IIIA) (48.0g) in chloroform was added dropwise within 2 hours, and the temperature was raised to 30-35°C to react for 15h. The reaction solution was concentrated to dryness under reduced pressure, and 100ml of methy...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an industrial preparation method for lamivudine (3TC). The method is characterized in that: 5-hydroxyl-1,3-oxathiolane-2-carboxylic acid [(1<,>R, 2<,>S, 5<,>R)-5<,>-methyl-2<,>-(1-methylethyl) cyclohexyl] ester reacts with a acylating agent to obtain a acylate; the acylate and monosilylated acyl cytosine or monosilylated cytosine schiff's base are subjected to a glycosylation through a catalysis of lewis acid to obtain a 3TC intermediate, followed by reducing and deacylating or hydrolyzing and reducing to obtain the 3TC. The method provided by the present invention has advantages of simple, available and cheap raw materials, simple operation, safe production, high yield, less waste pollution, and is applicable for industrial production.

Description

technical field [0001] The invention belongs to the field of chemistry or pharmaceutical chemistry, and in particular relates to an industrialized preparation method of anti-hepatitis B virus drug lamivudine. Background technique [0002] Lamivudine (Lamivudine, 3TC) is shown in formula (I), and its chemical name is (2R-cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolane -5-yl)-1H-pyrimidin-2-one is a nucleoside analog antiviral drug. Nucleotides are the raw materials for the synthesis of human genetic material DNA and RNA. Lamivudine mimics the structure of nucleotides in structure, but it does not have the function of nucleotides. Its mechanism of action is to inhibit viral DNA polymerase and reverse transcriptase activity, and has a competitive inhibitory effect on the synthesis and elongation of viral DNA chains. Therefore, in the process of DNA synthesis, nucleoside analogs can be incorporated, but they cannot synthesize nucleic acid chains with normal functions, so that ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D411/04
Inventor 蔡中文罗杰李洋叶文润易中宏樊斌邓杰
Owner 吉斯凯(苏州)制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap